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Gastric variceal bleeding is a major complication of portal hypertension and is associated
with high morbidity and mortality. While esophageal varices are more common, gastric
varices are often more challenging to treat. Balloon-Occluded Retrograde Transvenous
Obliteration is an interventional procedure whereby the portosystemic gastrorenal shunt is
accessed via the left renal vein and the gastric varix outflow tract obliterated using direct
sclerotherapy. Herein, we present a case of a 68-year-old female patient with cirrhosis who
presented with bleeding gastric varices and successfully treated. This case highlights the
procedural steps and the importance of detailed knowledge of the patient's portosystemic
anatomy for determining suitability for balloon-occluded retrograde transvenous obliter-
ation of gastric varices.
© 2016 the Authors. Published by Elsevier Inc. under copyright license from the University
of Washington. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Gastric varices (GV) develop in approximately 20% of patients
with portal hypertension [1]. Most GV are associated with a
left-sided spontaneous portosystemic shunt of varying
complexity. Although GV bleed less frequently as compared to
esophageal varices, GV bleeding is difficult to manage endo-
scopically due to their size, location, and high-volume blood
flow [2]. Furthermore, GV are associated with a higher risk of
rebleeding and increased mortality rate [3]. Balloon-occluded
retrograde transvenous obliteration (BRTO) is a safe andlared that no competing
l.ca (C.B. Lightfoot).
Elsevier Inc. under copy
se (http://creativecommoeffective procedure for treating GV and reducing the risk of
rebleeding [4]. BRTO involves temporary occlusion of outflow
veins of the portosystemic shunt followed by endovascular
injection of a sclerosant into the varix. Over the last 2 decades,
BRTO has been a common modality used for the prevention
and treatment of bleeding GV in Japan and various parts of
Asia. However, it has only recently gained wider attention in
North America and is still underused for treatment of GV. This
case describes the key clinical and anatomic features of GV in
a patient who was a suitable candidate and was successfully
treated with BRTO.interests exist.
right license from the University of Washington. This is an open
ns.org/licenses/by-nc-nd/4.0/).
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A 68-year-old woman with a history of liver disease was
transferred from a regional hospital to a tertiary care hospital
for urgent assessment and treatment of large GV along the
greater curvature of the stomach with previous bleeding.
Before arrival, the bleeding GV had been temporized with
endoscopic clip placement. On admission, the patient was
alert, oriented, and hemodynamically stable.
Laboratory investigations yielded the following results:
Hgb 90 (normal, 120-160) g/L, red blood cell count 3.8 (normal,
3.8-5.8) 1012/L, white blood cell count 7.8 (normal, 4.5-11)
109/L, and platelets 163 (normal, 150-350) 109/L. Her
cardiovascular and respiratory examinations were unre-
markable. Her abdomen was soft and nontender. There was
no peripheral edema or any other stigmata of chronic liver
disease (Child-Pugh class A). Her medical history was signifi-
cant for anemia, diabetes, hypertension, dyslipidemia, cho-
lecystectomy, and cirrhosis. Hepatology and interventional
radiology services assessed her for possible consideration of
BRTO for treatment of the GV.
Triphasic computed tomography (CT) of the abdomen and
pelvis was performed with noncontrast, arterial, and porto-
venous phase multiplanar imaging. Very large GV were found
in association with a splenorenal shunt draining into the left
renal vein (LRV; Figs. 1 and 2A). There was no evidence of
esophageal varices. The portal venous system, hepatic veins,
and inferior vena cavawere all patent. The liver demonstrated
nodular contour and morphologic changes in keeping with
cirrhosis. Based on the clinical and imaging findings of large
GV with prior bleeding in the setting of a gastrorenal shunt,
she was deemed a suitable candidate for BRTO treatment.
The BRTO procedural steps are illustrated in Figures 3A-F.
Briefly, needle access to the right common femoral vein was
achieved under ultrasound guidance. The vascular sheath andFig. 1 e Volume-rendered image from a preprocedure CT
showing a large gastric varix with a gastrorenal shunt
(arrow 1) draining into the left renal vein (LRV). The portal
vein (arrow 2), LRV (arrow 3), splenic vein (arrow 4), and
inferior vena cava (IVC) are also indicated.C2-shaped catheter were advanced over the wire, and the LRV
was selected. Venography was performed to identify the
inferior phrenic vein (Figs 3A and B). A Berenstein catheter
was used to select the gastrorenal shunt over a Glide wire
(Figs 3C and D). Balloon-occluded venogram was performed
through a 10-French sheath with an 11.5-mm occlusion
balloon, outlining the entire extent of the GV with reflux into
the splenic vein via the posterior gastric vein (Fig. 3E). A C-arm
(cone-beam) CT was performed with the occlusion balloon
inflated to outline the varices with trapped contrast. A total of
240 mg of 3% sodium tetradecyl sulphate foam was injected
(air, sodium tetradecyl sulphate, and lipiodol ratio of 3:2:1;
Fig. 3F). A C-arm CT was subsequently performed, which
confirmed good filling of the GV with the sclerosing agent.
With the occlusion balloon left in place, the patient was
transferred to the step down unit and monitored during the
sclerosant dwell time. Repeat fluoroscopy and C-arm CT were
preformed 6 hours later. The patient had an uncomplicated
recovery and was discharged home 4 days later. Follow-up CT
performed 3months later showed complete obliteration of her
GV (Fig. 2B). Upper gastroscopy was performed 10 months
post-BRTO which revealed the presence of small esophageal
varices, but no GV were seen.Discussion
GV are submucosal venous saccules in the wall of the stom-
ach, which develop in about 20% of patients with portal hy-
pertension [1]. They are classified according to Sarin et al [1] as
either gastroesophageal varices (GOV) or isolated GV (IGV).
GOV are further subdivided into two types: GOV1 (varices
continuous with esophageal varices, extending down to the
cardia, or lesser curve), and GOV2 (varices extending from
the esophagus toward the fundus). IGV may be found in the
fundus (IGV1) and are often tortuous and complex, or may be
located elsewhere in the stomach (IGV2) such as the antrum,
corpus, or around the pylorus [1,3]. GOV1 account for most GV
(75%), however, according to a prospective study, the inci-
dence of bleeding is significantly higher for IGV1 (78% for IGV1
vs 55% for GOV2, and 10% for GOV1 and IGV2) [1]. In com-
parison with esophageal varices, GV bleeding occurs less
frequently but is associated with a poorer prognosis. GV
bleeding results in greater hemorrhage and transfusion
requirements, as well as increased risk of rebleeding and
higher mortality rate [3]. Endoscopy is required to distinguish
between an esophageal and gastric source of bleeding and is
the first-line assessment modality for management of GV
bleeding. However, a prospective study of patients with
cirrhosis and GV hemorrhage and/or high-risk GV found that
conventional endoscopic measures such as sclerotherapy
may be associated with a higher rebleed rate as compared to
BRTO [5].
The vast majority of GV are associated with a spontaneous
left-sided portosystemic shunt, which can include gastro-
renal, direct gastrocaval, and gastrocaval shunts via the
inferior phrenic vein [2]. These shunts form to relieve portal
hypertension or to bypass portal venous obstruction. Gastro-
renal shunts are the most common, making up 80%-85% of
left-sided portosystemic shunts [2]. They create an outflow
Fig. 2 e Computed tomography pre-BRTO and post-BRTO. (A) Axial CT images acquired at portal venous phase
demonstrating large fundal GV (arrow). (B) Follow-up CT 3 months later showing resolution of varices after BRTO.
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systemic system. The gastric variceal system, which includes
the varices and gastrorenal shunt, can vary in complexity,
tortuosity, size, and blood flow. Hence, understanding the
anatomy and hemodynamics of the gastric variceal systemFig. 3 e BRTO procedural steps. (A) Left renal venogram via she
incidentally filling inferiorly. (B) Inferior phrenic and/or adrenal
advanced into the gastrorenal shunt for support. (D) Variceal ou
injection. (E) With occlusion balloon catheter inflated, the entiret
splenic vein origin. (F) Mixed density from the sclerosant foamthrough preprocedural imaging studies using CT is critical for
clinical management decisions [2].
BRTO involves occlusion of the portosystemic outflow
veins with a balloon catheter, followed by injection of a
sclerosing agent into the varix. The venous access site is theath with catheter tip at the renal hilum. Gonadal veins are
vein confluence is catheterized. (C) A catheter is carefully
tflow is delineated with digital subtraction contrast
y of the gastrorenal shunt and GV are delineated back to the
injection throughout the shunt and/or variceal complex.
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balloon is kept in place for hours to ensure that there is
sufficient dwelling of the sclerosingmaterial within the varix
and to minimize complications due to reflux into systemic or
portal vessels. The sclerosant results in thrombosis of the GV
and draining portosystemic shunt, which marks the end
point of the procedure. According to a retrospective study,
balloon rupture may occur in about 15% of BRTO procedures,
with no significant clinical or technical consequences [6].
However, technical failure may result if balloon rupture
occurs early, before thrombosis and complete sclerosis is
achieved [7].
There are 2 main clinical indications for BRTO: (1)
impending, prior, or active gastric variceal bleeding and (2)
GV with hepatic encephalopathy refractory to medical
management [7]. Relative contraindications include: severe
coagulopathy (often associated with liver failure), splenic
vein thrombosis, portal vein thrombosis, and uncontrolled
esophageal variceal bleeding unless BRTO is combined with
transjugular intrahepatic portosystemic shunts (TIPS). Of
these, the presence of chronic portal vein thrombosis may
be the most serious contraindication, as the gastrorenal
shunt could be the only splanchnic outflow tract. Thus, its
obliteration with BRTO poses the greatest risk for adverse
consequences due to splenic engorgement, thrombosis, and
venous mesenteric ischemia [7]. It is therefore imperative
to conduct preprocedural CT imaging to document the
presence of a portosystemic shunt and assess the patency
of the portal vein. Furthermore, due to variability in the
portosystemic as well as afferent and efferent venous col-
laterals feeding the GV, knowledge of the patient’s porto-
systemic anatomy is critical before performing the BRTO
procedure.
Endovascular radiologic management of bleeding GV
includes TIPS, which results in decompression of the portal
circulation, and BRTO, which leads to obliteration of varices
and their feeding shunts. Balloon-occluded antegrade trans-
venous obliteration is an alternate approach that occludes the
inflow to the varices from the portal system and can be per-
formed by direct transhepatic puncture of the portal veins or
via access through a TIPS shunt. These strategies can be used
alone or in combination depending on the patient’s clinical
characteristics and imaging findings. Guidelines for manage-
ment of GV are less well established as compared with
esophageal varices. According to a recent meta-analysis, TIPS
and BRTO appear to be similar in efficacy for controlling
bleeding GV [8]; however, TIPS has shown more consistent
results in treatment of esophageal varices [2]. The inconsis-
tency in TIPS outcomes for GV treatment is thought to be due
to the large gastrorenal shunt and variability in blood flow.
Furthermore, the effectiveness of TIPS in decompressing the
GV may also be dependent on the pattern of gastric vein
dominance [2]. TIPS is associated with a low but not insignif-
icant complication rate, which includes aggravation or
development of hepatic encephalopathy, bleeding, and even
death.
One of the greatest advantages of BRTO over TIPS is that it
improves hepatic blood flow and liver function, thereby
improving hepatic encephalopathy. This has been demon-
strated by several studies including a recent meta-analysiscomparing BRTO to TIPS for treatment of GV [8]. However,
BRTO also increases the risk of new-onset or worsening
esophageal variceal bleeding by closing the portal outflow
shunt and thus altering local hemodynamics and collateral
flow [9]. Therefore, patients should be closely monitored with
upper endoscopy post-BRTO for detection andmanagement of
esophageal varices [4]. Increased portal pressure may also
increase the risk of ascites and pleural effusion in some cases
[10]. Complications post-BRTO include fever, epigastric, chest
and/or back pain, transient systemic hypertension, pleural
effusion, and hemoglobinuria [10].
BRTO has excellent clinical and technical success rates
(79%-100%) with a recent systematic review of 24 studies
identifying BRTO as an efficacious and relatively safe pro-
cedure for treatment of GV [4]. Furthermore, in comparison to
endoscopic-guided sclerotherapy or cyanoacrylate injection
as primary treatment for GV, BRTO had a lower rebleed rate
[5]. A meta-analysis comparing BRTO to TIPS in patients with
GV and portal hypertension found them to be similar in terms
of technical success rate, hemostasis rate, and incidence of
postoperative complications, but BRTO was associated with a
lower incidence of rebleeding and encephalopathy [8]. GV
rebleed rates after a successful BRTO procedure range from0%
to 10% [9].
This case of isolated gastric variceal bleeding illustrates the
portosystemic anatomy that allows for successful treatment
with BRTO. In North America, expertise and utilization of
BRTO for managing gastric variceal hemorrhage is still not
widespread. Furthermore, large randomized controlled trials
are lacking, and hence, more robust data are needed. None-
theless, according to the best available evidence, if the tech-
nical expertise is available, BRTO should be considered for the
management of significant GV [4,8].r e f e r e n c e s
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